96 related articles for article (PubMed ID: 15254744)
1. Usefulness of immunomodulators for maturation of dendritic cells.
Ogihara T; Iinuma H; Okinaga K
Int J Oncol; 2004 Aug; 25(2):453-9. PubMed ID: 15254744
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of dendritic cells matured early with OK-432 (Picibanil), prostaglandin E2, and interferon-alpha as a vaccine for a hormone refractory prostate cancer cell line.
Yoo C; Do HA; Jeong IG; Park H; Hwang JJ; Hong JH; Cho JS; Choo MS; Ahn H; Kim CS
J Korean Med Sci; 2010 Sep; 25(9):1284-90. PubMed ID: 20808670
[TBL] [Abstract][Full Text] [Related]
4. Streptococcal preparation OK432 promotes functional maturation of human monocyte-derived dendritic cells.
Itoh T; Ueda Y; Okugawa K; Fujiwara H; Fuji N; Yamashita T; Fujiki H; Harada S; Yoshimura T; Yamagishi H
Cancer Immunol Immunother; 2003 Apr; 52(4):207-14. PubMed ID: 12669245
[TBL] [Abstract][Full Text] [Related]
5. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells.
Koido S; Hara E; Homma S; Torii A; Mitsunaga M; Yanagisawa S; Toyama Y; Kawahara H; Watanabe M; Yoshida S; Kobayashi S; Yanaga K; Fujise K; Tajiri H
J Immunol; 2007 Jan; 178(1):613-22. PubMed ID: 17182602
[TBL] [Abstract][Full Text] [Related]
6. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
7. Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran).
Ghoneum M; Agrawal S
Int J Immunopathol Pharmacol; 2011; 24(4):941-8. PubMed ID: 22230400
[TBL] [Abstract][Full Text] [Related]
8. Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use.
Kuroki H; Morisaki T; Matsumoto K; Onishi H; Baba E; Tanaka M; Katano M
Cancer Immunol Immunother; 2003 Sep; 52(9):561-8. PubMed ID: 14627128
[TBL] [Abstract][Full Text] [Related]
9. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
[TBL] [Abstract][Full Text] [Related]
11. Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2.
Karlsen M; Hovden AO; Vogelsang P; Tysnes BB; Appel S
Scand J Immunol; 2011 Aug; 74(2):135-43. PubMed ID: 21449940
[TBL] [Abstract][Full Text] [Related]
12. Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.
Zhu M; Xu W; Su H; Huang Q; Wang B
Hum Vaccin Immunother; 2015; 11(7):1596-605. PubMed ID: 26039883
[TBL] [Abstract][Full Text] [Related]
13. Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2).
Sato M; Takayama T; Tanaka H; Konishi J; Suzuki T; Kaiga T; Tahara H
Cancer Sci; 2003 Dec; 94(12):1091-8. PubMed ID: 14662025
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of circulating dendritic cell activity by immunomodulators (OK432 and KP-40).
Toyokawa H; Inaba M; Takai S; Satoi S; Beuth J; Ko HL; Matsui Y; Kwon AH; Kamiyama Y; Ikehara S
Anticancer Res; 2002; 22(4):2137-45. PubMed ID: 12174895
[TBL] [Abstract][Full Text] [Related]
15. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
16. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
Tanaka F; Yamaguchi H; Haraguchi N; Mashino K; Ohta M; Inoue H; Mori M
Int J Oncol; 2006 Nov; 29(5):1263-8. PubMed ID: 17016660
[TBL] [Abstract][Full Text] [Related]
17. The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers.
Shu YQ; Gu Y
Biomed Pharmacother; 2006 May; 60(4):156-60. PubMed ID: 16647239
[TBL] [Abstract][Full Text] [Related]
18. Maturation and cytokine production potential of dendritic cells isolated from rheumatoid arthritis patients peripheral blood and induced in vitro.
Sennikov SV; Falaleeva SA; Shkaruba NS; Chumasova OA; Obleukhova IA; Sizikov AE; Kurilin VV
Hum Immunol; 2016 Oct; 77(10):930-936. PubMed ID: 27421624
[TBL] [Abstract][Full Text] [Related]
19. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
20. 3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E
Yi DH; Stetter N; Jakobsen K; Jonsson R; Appel S
Cancer Immunol Immunother; 2018 Oct; 67(10):1611-1620. PubMed ID: 30069688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
